CPP is pleased to announce a new partnership with Dynavax, the manufacturer of the newly approved adult hepatitis-B vaccine Heplisav-B® administered as a 2-dose series. (April 2018 MMWR publication of the ACIP recommendation)
Members of CPP who opt-into the Dynavax contract can access discounted pricing on doses of Heplisav-B® purchased through an authorized distributor. For a complete list of authorized distributors, see attached list or call 1-84-HEPLISAV (1-844-375-4728).
Members who are interested in participating in the CPP/Dynavax contract should contact the CPP office at 614-722-2145 or email@example.com to obtain an opt-in form.
If you have any questions, please don’t hesitate to contact us!